An economic analysis of varicella vaccination for health care workers

Epidemiology and Infection

Volumn 119, Issue 2, 1997, Pages 209-220

  Gray, A M ^a   Fenn, P ^b   Weinberg, J ^c   Miller, E ^d   McGuire, A ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WOLFSON COLLEGE   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ARTICLE; CHICKENPOX; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; OCCUPATIONAL HEALTH;

CHICKENPOX; CHICKENPOX VACCINE; COST SAVINGS; COST-BENEFIT ANALYSIS; CROSS INFECTION; DECISION TREES; HEALTH CARE COSTS; HUMANS; INCIDENCE; INFECTION CONTROL; MASS SCREENING; PERSONNEL, HOSPITAL; SENSITIVITY AND SPECIFICITY; VACCINATION;

EID: 0030657448     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268897007887     Document Type: Article

References (19)

1. Weber DJ, Rutala WA, Parham C. Impact and cost of varicella prevention in a university hospital. Am J Pub Health 1988; 78: 19-23.
2. Krasinski K, Holzman RS, LaCouture R, Florman A. Hospital experience with varicella-zoster virus. Infect Control 1986; 7: 312-6.
3. Miller PJ, Landry S, Searcy MA, Hunt E, Wenzel RP. Cost of varicella epidemic. Pediatrics 1985; 75: 989-90.
4. Hyams PJ, Stuewe MCS, Heitzer V. Herpes zoster causing varicella (chicken pox) in hospital employees: cost of a casual attitude. Infect Control 1984; 12: 2-5.
5. Wreghitt TG, Whipp J, Redpath C, Hollingworth W. An analysis of infection control of varicella-zoster virus infections in Addenbrooke's Hospital Cambridge over a 5-year period, 1987-92. Epidemiol Infect 1996; 117: 167-71.
6. Asano Y, Suga S, Yoshikawa T, et al. Experience and reason : twenty year follow up of protective immunity of the Oka strain live varicella vaccine. Pediatrics 1994; 94: 524-6.
7. Kitai IC, King S, Gafni A. An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients. Clin Infect Dis 1993; 17: 441-7.
8. Preblud SR, Orenstein WA, Koplan JP, Bart KJ, Hinman AR. A benefit-cost analysis of childhood varicella vaccination programme. Postgrad Med 1985; 61: 17-22.
9. Lieu TA, Cochi SL, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994; 271: 375-81.
10. Lieu TA, Black SB, Shinefield HR, et al. Routine childhood varicella vaccination. JAMA 1994; 271: 1906.
11. Gershon AA, Steinberg SP, LaRussa P, Ferrera A, Hammerschlag M, Gelb L, and the NIAIA varicella Collaborative Study Group. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis 1988; 158: 132-7.
12. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996; 313: 275-83.
13. Murray A, Kangro HO, Health RB. Screening hospital staff for antibodies to varicella-zoster virus. Lancet 1990; ii: 192.
14. Miller E, Marshall R, Vurdien J. Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 1993; 4: 222-30.
15. Fairley CK, Miller E. Varicella-Zoster virus epidemiology - a changing scene. J Infect Dis 1996; 175: S314-S319.
16. Health Care Information Services. The Fitzhugh Directory of NHS Trusts: 1995. London: Health Care Information Services, 1995.
17. Chartered Institute of Public Finance and Accountancy. NHS Trust database. London: CIPFA, 1994.
18. Morgan-Capner P, Wilson M, Wright J, Hutchinson DN. Varicella and zoster in hospitals. Lancet 1991; i: 1960.
19. Miller E, Vurdien J, Farrington P. Shift in age in chickenpox. Lancet 1993; 341: 308-9.